BE-80-2400381 group 7, 8 and 9

Study to treat autoimmune diseases (group 7, 8 and 9)

Are you

  • a healthy male or (infertile*) female
  • between 18 and 65 years (inclusive)
  • with a BMI between 18 and 30 kg/m² (inclusive)
    • weight between 50 and 100 kg
  • who does not smoke or quit smoking at least 3 months prior to screening (including nicotine containing products like e.g. nicotine patches)

  • who does not use daily medication

*postmenopausal (no menses for at least 12 months), uterus removal, removal of both fallopian tubes or both ovaries.

What does this trial involve?

SGS trial BE-80-2400381 investigates the treatment of autoimmune diseases. During +/- 6 months you will have the following appointments:

  • a screening visit
  • a stay of 9 days (8 nights) at our unit
  • 8 morning return visits
  • 1 follow-up phone call
  • an end of trial visit

Take part in this trial and

  • help us develop tomorrow's medicines
  • and receive a financial compensation

This study was approved by the competent Belgian health authorities and an independent ethics committee.

View information leaflet group 8.2

View information leaflet group 8.3

View information leaflet group 9.2

View information leaflet group 9.3

Any other questions?

Ask your question